Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study

Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes

(2020) Anjali Gopalan et al.   DIABETES CARE

Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study

(2020) Hongjiang Wu et al.   DIABETOLOGIA

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study

(2020) Andrea O. Y. Luk et al.   PLOS MEDICINE

Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes

(2019) Calvin Ke et al.   ANNALS OF INTERNAL MEDICINE

A pre‐specified statistical analysis plan for the VERIFY study: vildagliptin efficacy in combination with metformin for early treatment of T2DM

(2019) David R. Matthews et al.   DIABETES OBESITY & METABOLISM

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis

(2019) Yue Fei et al.   Cardiovascular Diabetology

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

(2019) David R Matthews et al.   LANCET

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2019) John B. Buse et al.   DIABETOLOGIA

Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis

(2018) Xiaoling Cai et al.   Diabetes Therapy

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETES CARE

Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy—The Hong Kong Diabetes Registry

(2016) Guozhi Jiang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

(2016) William Polonsky et al.   Patient Preference and Adherence

Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis

(2014) Juliana C.N. Chan et al.   AMERICAN JOURNAL OF MEDICINE

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

(2014) Roseanne O Yeung et al.   Lancet Diabetes & Endocrinology

Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis

(2013) Y. G. Kim et al.   DIABETOLOGIA

Therapy in the Early Stage: Incretins

(2011) S. Cernea et al.   DIABETES CARE

Diabetes in Asia

(2009) Juliana C. N. Chan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

β-cell failure as a complication of diabetes

(2008) K. J. Chang-Chen et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS